Janus Henderson Group PLC Has $1.80 Million Holdings in Bath & Body Works, Inc. $BBWI

Janus Henderson Group PLC trimmed its stake in shares of Bath & Body Works, Inc. (NYSE:BBWIFree Report) by 87.3% during the first quarter, Holdings Channel.com reports. The firm owned 96,600 shares of the company’s stock after selling 666,311 shares during the period. Janus Henderson Group PLC’s holdings in Bath & Body Works were worth $1,803,000 at the end of the most recent reporting period.

Other hedge funds have also modified their holdings of the company. Royal Bank of Canada raised its position in Bath & Body Works by 92.8% in the 1st quarter. Royal Bank of Canada now owns 59,877 shares of the company’s stock worth $1,815,000 after purchasing an additional 28,815 shares during the last quarter. Goldman Sachs Group Inc. boosted its position in Bath & Body Works by 15.7% in the 1st quarter. Goldman Sachs Group Inc. now owns 645,970 shares of the company’s stock valued at $19,586,000 after buying an additional 87,529 shares during the last quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC increased its stake in shares of Bath & Body Works by 7.0% in the 1st quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 562,757 shares of the company’s stock valued at $17,063,000 after buying an additional 36,684 shares during the period. Intech Investment Management LLC acquired a new stake in shares of Bath & Body Works in the 1st quarter valued at $1,155,000. Finally, Geneos Wealth Management Inc. raised its position in shares of Bath & Body Works by 217.7% during the first quarter. Geneos Wealth Management Inc. now owns 1,169 shares of the company’s stock worth $35,000 after acquiring an additional 801 shares during the last quarter. 95.14% of the stock is owned by institutional investors.

Analyst Ratings Changes

Several equities analysts have recently issued reports on BBWI shares. Wells Fargo & Company upped their price target on Bath & Body Works from $25.00 to $26.00 and gave the company an “overweight” rating in a research note on Tuesday, June 23rd. Weiss Ratings raised Bath & Body Works from a “sell (d+)” rating to a “hold (c-)” rating in a report on Thursday, July 9th. Morgan Stanley restated an “equal weight” rating and set a $22.00 target price on shares of Bath & Body Works in a research report on Monday, July 6th. UBS Group reduced their target price on shares of Bath & Body Works from $22.00 to $19.00 and set a “neutral” rating on the stock in a research note on Wednesday, May 20th. Finally, Barclays lowered their price target on shares of Bath & Body Works from $25.00 to $23.00 and set an “equal weight” rating for the company in a research report on Thursday, May 28th. Three analysts have rated the stock with a Buy rating, fourteen have assigned a Hold rating and one has issued a Sell rating to the stock. Based on data from MarketBeat, the company has a consensus rating of “Hold” and an average price target of $21.93.

Get Our Latest Stock Report on Bath & Body Works

Bath & Body Works Stock Performance

Shares of BBWI opened at $20.34 on Monday. Bath & Body Works, Inc. has a twelve month low of $14.27 and a twelve month high of $32.32. The firm’s 50 day moving average price is $20.30 and its two-hundred day moving average price is $20.27. The firm has a market cap of $4.10 billion, a P/E ratio of 5.71, a PEG ratio of 2.01 and a beta of 1.38.

Bath & Body Works (NYSE:BBWIGet Free Report) last released its quarterly earnings results on Wednesday, May 27th. The company reported $0.32 earnings per share for the quarter, beating the consensus estimate of $0.29 by $0.03. Bath & Body Works had a net margin of 10.03% and a negative return on equity of 45.34%. The company had revenue of $1.38 billion during the quarter, compared to analysts’ expectations of $1.36 billion. During the same quarter in the prior year, the company earned $0.49 earnings per share. The business’s quarterly revenue was down 3.2% compared to the same quarter last year. Bath & Body Works has set its Q2 2026 guidance at 0.300-0.300 EPS and its FY 2026 guidance at 2.400-2.650 EPS. On average, sell-side analysts anticipate that Bath & Body Works, Inc. will post 2.63 earnings per share for the current fiscal year.

Bath & Body Works Dividend Announcement

The company also recently declared a quarterly dividend, which will be paid on Friday, September 4th. Shareholders of record on Friday, August 21st will be given a dividend of $0.20 per share. The ex-dividend date of this dividend is Friday, August 21st. This represents a $0.80 dividend on an annualized basis and a yield of 3.9%. Bath & Body Works’s dividend payout ratio is 22.47%.

Bath & Body Works Company Profile

(Free Report)

Bath & Body Works, Inc is a leading specialty retailer focused on personal care, home fragrance and complementary products. Through its flagship Bath & Body Works brand, the company offers a diverse assortment of shower gels, lotions, fragrance mists, candles and home fragrance items. Its product portfolio also includes the White Barn Candle Co range of premium scented candles and diffusers. Bath & Body Works serves consumers through a combination of brick-and-mortar stores and e-commerce platforms, delivering seasonal collections, limited-edition releases and signature scent lines.

Founded in 1990 as part of Limited Brands (now L Brands), Bath & Body Works opened its first store in New Albany, Ohio, and quickly expanded across the United States.

Featured Stories

Want to see what other hedge funds are holding BBWI? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Bath & Body Works, Inc. (NYSE:BBWIFree Report).

Institutional Ownership by Quarter for Bath & Body Works (NYSE:BBWI)

Receive News & Ratings for Bath & Body Works Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Bath & Body Works and related companies with MarketBeat.com's FREE daily email newsletter.